Quantum BioPharma Signs Study Start-Up Deal for Lucid-MS Phase 2 Trial
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher's PPD to commence its FDA-cleared Phase 2 trial of Lucid-MS for progressive MS.
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher's PPD to commence its FDA-cleared Phase 2 trial of Lucid-MS for progressive MS.